M980-M994
Morphology Classification: Leukaemias
- M9800/3Leukaemia, NOS, malignant, primary site (C95.9)
- M9801/3Acute leukaemia, NOS, malignant, primary site (C95.0)
- M9802/3Subacute leukaemia NOS, malignant, primary site (C95.2)
- M9803/3Chronic leukaemia NOS, malignant, primary site (C95.1)
- M9804/3Aleukaemic leukaemia NOS, malignant, primary site (C95.7)
- M9805/3Acute biphenotypic leukaemia, malignant, primary site
- M9805/6Acute biphenotypic leukaemia, malignant, metastatic site
- M9806/3Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1, malignant, primary site
- M9806/6Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1, malignant, metastatic site
- M9807/3Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged, malignant, primary site
- M9807/6Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged, malignant, metastatic site
- M9808/3Mixed phenotype acute leukaemia, B/myeloid, NOS, malignant, primary site
- M9808/6Mixed phenotype acute leukaemia, B/myeloid, NOS, malignant, metastatic site
- M9809/3Mixed phenotype acute leukaemia, T/myeloid, NOS, malignant, primary site
- M9809/6Mixed phenotype acute leukaemia, T/myeloid, NOS, malignant, metastatic site
- M9811/3B lymphoblastic leukaemia/lymphoma, NOS, malignant, primary site
- M9811/6B lymphoblastic leukaemia/lymphoma, NOS, malignant, metastatic site
- M9812/3B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1, malignant, primary site
- M9812/6B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1, malignant, metastatic site
- M9813/3B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged, malignant, primary site
- M9813/6B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged, malignant, metastatic site
- M9814/3B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1), malignant, primary site
- M9814/6B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1), malignant, metastatic site
- M9815/3B lymphoblastic leukaemia/lymphoma with hyperdiploidy, malignant, primary site
- M9815/6B lymphoblastic leukaemia/lymphoma with hyperdiploidy, malignant, metastatic site
- M9816/3B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL), malignant, primary site
- M9816/6B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL), malignant, metastatic site
- M9817/3B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH, malignant, primary site
- M9817/6B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH, malignant, metastatic site
- M9818/3B lymphoblastic leukaemia/lymphoma with t (1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1), malignant, primary site
- M9818/6B lymphoblastic leukaemia/lymphoma with t (1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1), malignant, metastatic site
- M9820/3Lymphoid leukaemia, NOS, malignant, primary site (C91.9)
- M9821/3Acute lymphoblastic leukaemia NOS, malignant, primary site (C91.0)
- M9822/3Subacute lymphoid leukaemia, malignant, primary site (C91.2)
- M9823/3Chronic lymphocytic leukaemia (C91.1)
- M9824/3Aleukaemic lymphoid leukaemia, malignant, primary site (C91.7)
- M9825/3Prolymphocytic leukaemia, malignant, primary site (C91.3)
- M9826/3Burkitt's cell leukaemia (C91.7)
- M9827/3Adult T-cell leukaemia/lymphoma (C91.5)
- M9830/3Plasma cell leukaemia, malignant, primary site (C90.1)
- M9831/1T-cell large granular lymphocytic leukaemia, uncertain whether benign or malignant
- M9831/3T-cell large granular lymphocytic leukaemia, malignant, primary site
- M9831/6T-cell large granular lymphocytic leukaemia, malignant, metastatic site
- M9832/3Prolymphocytic leukaemia, NOS, malignant, primary site
- M9832/6Prolymphocytic leukaemia, NOS, malignant, metastatic site
- M9833/3Prolymphocytic leukaemia, B-cell type, malignant, primary site
- M9833/6Prolymphocytic leukaemia, B-cell type, malignant, metastatic site
- M9834/3Prolymphocytic leukaemia, T-cell type, malignant, primary site
- M9834/6Prolymphocytic leukaemia, T-cell type, malignant, metastatic site
- M9835/3Precursor cell lymphoblastic leukaemia, NOS, malignant, primary site
- M9835/6Precursor cell lymphoblastic leukaemia, NOS, malignant, metastatic site
- M9836/3Precursor B-cell lymphoblastic leukaemia, malignant, primary site
- M9836/6Precursor B-cell lymphoblastic leukaemia, malignant, metastatic site
- M9837/3Precursor T-cell lymphoblastic leukaemia, malignant, primary site
- M9837/6Precursor T-cell lymphoblastic leukaemia, malignant, metastatic site
- M9840/3Erythroleukaemia (C94.0)
- M9841/3Acute erythraemia, malignant, primary site (C94.0)
- M9842/3Chronic erythraemia, malignant, primary site (C94.0)
- M9850/3Lymphosarcoma cell leukaemia, malignant, primary site (C94.7)
- M9860/3Myeloid leukaemia, NOS (C92.9)
- M9861/3Acute myeloid leukaemia, NOS, malignant, primary site
- M9862/3Subacute myeloid leukaemia, malignant, primary site (C92.2)
- M9863/3Chronic myeloid leukaemia (C92.1)
- M9864/3Aleukaemic myeloid leukaemia, malignant, primary site (C92.7)
- M9865/3Acute myeloid leukaemia with t(6;9)(p23:q34); DEK-NUP214, malignant, primary site
- M9865/6Acute myeloid leukaemia with t(6;9)(p23:q34); DEK-NUP214, malignant, metastatic site
- M9866/3Acute promyelocytic leukaemia (C92.7)
- M9867/3Acute myelomonocytic leukaemia, malignant, primary site (C92.5)
- M9868/3Chronic myelomonocytic leukaemia, malignant, primary site (C92.7)
- M9869/3Acute myeloid leukaemia with inv(3)(q21A26.2) or t(3;3)(q21;Q26.2); RPN1-EVI1, malignant, primary site
- M9869/6Acute myeloid leukaemia with inv(3)(q21A26.2) or t(3;3)(q21;Q26.2); RPN1-EVI1, malignant, metastatic site
- M9870/3Basophilic leukaemia (C92.-)
- M9871/3Acute myeloid leukaemia with abnormal marrow eosinophils, malignant, primary site
- M9871/6Acute myeloid leukaemia with abnormal marrow eosinophils, malignant, metastatic site
- M9872/3Acute myeloid leukaemia, minimal differentiation, malignant, primary site
- M9872/6Acute myeloid leukaemia, minimal differentiation, malignant, metastatic site
- M9873/3Acute myeloid leukaemia without maturation, malignant, primary site
- M9873/6Acute myeloid leukaemia without maturation, malignant, metastatic site
- M9874/3Acute myeloid leukaemia with maturation, malignant, primary site
- M9874/6Acute myeloid leukaemia with maturation, malignant, metastatic site
- M9875/3Chronic myelogenous leukaemia, BCR/ABL positive, malignant, primary site
- M9875/6Chronic myelogenous leukaemia, BCR/ABL positive, malignant, metastatic site
- M9876/3Atypical chronic myeloid leukaemia, BCR/ABL negative, malignant, primary site
- M9876/6Atypical chronic myeloid leukaemia, BCR/ABL negative, malignant, metastatic site
- M9880/3Eosinophilic leukaemia, malignant, primary site (C92.-)
- M9890/3Monocytic leukaemia NOS, malignant, primary site (C93.9)
- M9891/3Acute monocytic leukaemia, malignant, primary site (C93.0)
- M9892/3Subacute monocytic leukaemia, malignant, primary site (C93.2)
- M9893/3Chronic monocytic leukaemia, malignant, primary site (C93.1)
- M9894/3Aleukaemic monocytic leukaemia, malignant, primary site (C93.7)
- M9895/3Acute myeloid leukaemia with myelodysplasia-related changes, malignant, primary site
- M9895/6 Acute myeloid leukaemia with myelodysplasia-related changes, malignant, metastatic site
- M9896/3Acute myeloid leukaemia, t(8;21)(q22;q22), malignant, primary site
- M9896/6Acute myeloid leukaemia, t(8;21)(q22;q22), malignant, metastatic site
- M9897/3Acute myeloid leukaemia, 11q23 abnormalities, malignant, primary site
- M9897/6Acute myeloid leukaemia, 11q23 abnormalities, malignant, metastatic site
- M9898/1Transient abnormal myelopoiesis, uncertain whether benign or malignant
- M9898/3Myeloid leukaemia associated with Down Syndrome, malignant, primary site
- M9898/6Myeloid leukaemia associated with Down Syndrome, malignant, metastatic site
- M9900/3Mast cell leukaemia, malignant, primary site (C94.3)
- M9910/3Acute megakaryoblastic leukaemia, malignant, primary site (C94.2)
- M9911/3Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1, malignant, primary site
- M9911/6Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1, malignant, metastatic site
- M9920/3Therapy related myeloid neoplasm, malignant, primary site
- M9930/3Myeloid sarcoma, malignant, primary site
- M9931/3Acute panmyelosis (C94.4)
- M9932/3Acute myelofibrosis, malignant, primary site (C94.5)
- M9940/3Hairy cell leukaemia, malignant, primary site (C91.4)
- M9941/3Leukaemic reticuloendotheliosis, malignant, primary site (C91.4)
- M9945/3Chronic myelomonocytic leukaemia, NOS, malignant, primary site
- M9945/6Chronic myelomonocytic leukaemia, NOS, malignant, metastatic site
- M9946/3Juvenile myelomonocytic leukaemia, malignant, primary site
- M9946/6Juvenile myelomonocytic leukaemia, malignant, metastatic site
- M9948/3Aggressive NK-cell leukaemia, malignant, primary site
- M9948/6Aggressive NK-cell leukaemia, malignant, metastatic site